These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
338 related articles for article (PubMed ID: 2165134)
21. Immune responses and protection against vaginal infection after nasal or vaginal immunization with attenuated herpes simplex virus type-2. Parr EL; Parr MB Immunology; 1999 Dec; 98(4):639-45. PubMed ID: 10594699 [TBL] [Abstract][Full Text] [Related]
22. Protective immunization of mice with specific HSV-1 glycoproteins. Chan WL Immunology; 1983 Jun; 49(2):343-52. PubMed ID: 6303950 [TBL] [Abstract][Full Text] [Related]
23. Immunity to vaginal infection by herpes simplex virus type 2 in adult mice: characterization of the immunoglobulins in vaginal mucus. Parr EL; Bozzola JJ; Parr MB J Reprod Immunol; 1998 Apr; 38(1):15-30. PubMed ID: 9616875 [TBL] [Abstract][Full Text] [Related]
24. Viral isolation and systemic immune responses after intracameral inoculation of herpes simplex virus type 1 in Igh-1-disparate congenic murine strains. Hemady R; Tauber J; Ihley TM; Opremcak EM; Foster CS Invest Ophthalmol Vis Sci; 1990 Nov; 31(11):2335-41. PubMed ID: 2173686 [TBL] [Abstract][Full Text] [Related]
25. Protective effect of an oral infection with herpes simplex virus type 1 against subsequent genital infection with herpes simplex virus type 2. Sturn B; Schneweis KE Med Microbiol Immunol; 1978 Jul; 165(2):119-27. PubMed ID: 209295 [TBL] [Abstract][Full Text] [Related]
26. Nasal and skin delivery of IC31(®)-adjuvanted recombinant HSV-2 gD protein confers protection against genital herpes. Wizel B; Persson J; Thörn K; Nagy E; Harandi AM Vaccine; 2012 Jun; 30(29):4361-8. PubMed ID: 22682292 [TBL] [Abstract][Full Text] [Related]
27. Immunity in the female genital tract after intravaginal vaccination of mice with an attenuated strain of herpes simplex virus type 2. McDermott MR; Smiley JR; Leslie P; Brais J; Rudzroga HE; Bienenstock J J Virol; 1984 Sep; 51(3):747-53. PubMed ID: 6088797 [TBL] [Abstract][Full Text] [Related]
28. Characterization and immunogenicity of HSV-1 antigens obtained following zwitterionic detergent treatment. Mukhlis FA; Jennings R; Stephenson TJ; Quasim T; Potter CW Vaccine; 1986 Sep; 4(3):191-6. PubMed ID: 3020821 [TBL] [Abstract][Full Text] [Related]
29. Protective immunity against herpes simplex virus (HSV) type 1 following oral administration of recombinant Salmonella typhimurium vaccine strains expressing HSV antigens. Karem KL; Bowen J; Kuklin N; Rouse BT J Gen Virol; 1997 Feb; 78 ( Pt 2)():427-34. PubMed ID: 9018066 [TBL] [Abstract][Full Text] [Related]
30. Effect of immunization on the development of latent ganglionic infection in mice challenged intravaginally with herpes simplex virus types 1 and 2. Asher LV; Walz MA; Notkins AL Am J Obstet Gynecol; 1978 Aug; 131(7):788-91. PubMed ID: 210669 [TBL] [Abstract][Full Text] [Related]
31. Influence of DNA encoding cytokines on systemic and mucosal immunity following genetic vaccination against herpes simplex virus. Lee S; Gierynska M; Eo SK; Kuklin N; Rouse BT Microbes Infect; 2003 Jun; 5(7):571-8. PubMed ID: 12787733 [TBL] [Abstract][Full Text] [Related]
32. Mucosal immunity to herpes simplex virus type 2 infection in the mouse vagina is impaired by in vivo depletion of T lymphocytes. Parr MB; Parr EL J Virol; 1998 Apr; 72(4):2677-85. PubMed ID: 9525585 [TBL] [Abstract][Full Text] [Related]
33. Vaccination with a HSV-2 UL24 mutant induces a protective immune response in murine and guinea pig vaginal infection models. Visalli RJ; Natuk RJ; Kowalski J; Guo M; Blakeney S; Gangolli S; Cooper D Vaccine; 2014 Mar; 32(12):1398-406. PubMed ID: 24462481 [TBL] [Abstract][Full Text] [Related]
34. Immunoglobulin G is the main protective antibody in mouse vaginal secretions after vaginal immunization with attenuated herpes simplex virus type 2. Parr EL; Parr MB J Virol; 1997 Nov; 71(11):8109-15. PubMed ID: 9343160 [TBL] [Abstract][Full Text] [Related]
35. Passive immunization of the vagina protects mice against vaginal transmission of genital herpes infections. Whaley KJ; Zeitlin L; Barratt RA; Hoen TE; Cone RA J Infect Dis; 1994 Mar; 169(3):647-9. PubMed ID: 8158042 [TBL] [Abstract][Full Text] [Related]
36. Specific secretory immune responses in the female genital tract following intranasal immunization with a recombinant adenovirus expressing glycoprotein B of herpes simplex virus. Gallichan WS; Rosenthal KL Vaccine; 1995 Nov; 13(16):1589-95. PubMed ID: 8578847 [TBL] [Abstract][Full Text] [Related]
37. Systemic immunodominant CD8 responses with an effector-like phenotype are induced by intravaginal immunization with attenuated HSV vectors expressing HIV Tat and mediate protection against HSV infection. Nicoli F; Gallerani E; Skarlis C; Sicurella M; Cafaro A; Ensoli B; Caputo A; Marconi PC; Gavioli R Vaccine; 2016 Apr; 34(19):2216-24. PubMed ID: 27002499 [TBL] [Abstract][Full Text] [Related]
38. The importance of MHC-I and MHC-II responses in vaccine efficacy against lethal herpes simplex virus type 1 challenge. Ghiasi H; Roopenian DC; Slanina S; Cai S; Nesburn AB; Wechsler SL Immunology; 1997 Jul; 91(3):430-5. PubMed ID: 9301533 [TBL] [Abstract][Full Text] [Related]
39. Genetic immunization against herpes simplex virus. Protection is mediated by CD4+ T lymphocytes. Manickan E; Rouse RJ; Yu Z; Wire WS; Rouse BT J Immunol; 1995 Jul; 155(1):259-65. PubMed ID: 7602102 [TBL] [Abstract][Full Text] [Related]
40. [Detection of antigen and antibody in herpes simplex encephalitis]. Smetana Z; Leventon-Kriss S; Gotlieb-Stematsky T Harefuah; 1989 Nov; 117(9):233-5. PubMed ID: 2559006 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]